What ST JUDE MEDICAL, LLC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Ellingson Rachel | VP, Global Communications | Jan 04 | Disposition to Issuer · D | −8,732 | — | — | 0 |
| Zellers Jason | VP, General Counsel & Corp Sec | Jan 04 | Disposition to Issuer · D | −19,214 | — | — | 0 |
| Murphy Mark W. | VP, IT and CIO | Jan 04 | Disposition to Issuer · D | −7,136 | — | — | 0 |
| Zurbay Donald | VP Finance and CFO | Jan 04 | Disposition to Issuer · D | −26,075 | — | — | 0 |
| Heinmiller John C | Executive Vice President | Jan 04 | Disposition to Issuer · D | −325,914 | — | — | 0 |
| Gestin Denis M | President, International | Jan 04 | Disposition to Issuer · D | −39,665 | — | — | 0 |
| Starks Daniel J | Director | Jan 04 | Disposition to Issuer · D | −6,315,961 | — | — | 0 |
| Ebeling Philip | VP, Chief Technology Officer | Jan 04 | Disposition to Issuer · D | −3,113 | — | — | 0 |
| Dvorak David C | Director | Jan 04 | Disposition to Issuer · D | −5,599 | — | — | 0 |
| Essig Stuart | Director | Jan 04 | Disposition to Issuer · D | −48,777 | — | — | 0 |
| Fain Eric S | Group President | Jan 04 | Disposition to Issuer · D | −130,716 | — | — | 0 |
| Rocca Michael A | Director | Jan 04 | Disposition to Issuer · D | −28,938 | — | — | 0 |
| Dallager Jeff | VP and Corporate Controller | Jan 04 | Disposition to Issuer · D | −8,641 | — | — | 0 |
| Widensohler Stefan K | Director | Jan 04 | Disposition to Issuer · D | −34,390 | — | — | 0 |
| Carlson Mark | Chief Medical Off-VP,Clinical | Jan 04 | Disposition to Issuer · D | −14,964 | — | — | 0 |
| Andrade Lisa | VP and Chief Marketing Officer | Jan 04 | Disposition to Issuer · D | −10,302 | — | — | 0 |
| Fecho Jeff | VP, Global Quality | Jan 04 | Disposition to Issuer · D | −7,259 | — | — | 0 |
| Thome Scott | VP, Global Ops & Supply Chain | Jan 04 | Disposition to Issuer · D | −3,801 | — | — | 0 |
| Bae I Paul | VP Global HR and CCO | Jan 04 | Disposition to Issuer · D | −20,421 | — | — | 0 |
| Yarno Wendy L | Director | Jan 04 | Disposition to Issuer · D | −30,240 | — | — | 0 |
Loading...
